TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 46 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $4,236,000 | +2.0% | 2,086,755 | 0.0% | 0.22% | +10.3% |
| Q2 2014 | $4,153,000 | -35.4% | 2,086,755 | 0.0% | 0.20% | -38.3% |
| Q1 2014 | $6,427,000 | -8.3% | 2,086,755 | 0.0% | 0.32% | -6.8% |
| Q4 2013 | $7,011,000 | +5.7% | 2,086,755 | 0.0% | 0.34% | +28.9% |
| Q3 2013 | $6,636,000 | +5.3% | 2,086,755 | 0.0% | 0.26% | -6.4% |
| Q2 2013 | $6,302,000 | – | 2,086,755 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|